Daniel Volz, the newly named head of Medtronic’s neurovascular group, explains how the company is developing game-changing technologies into devices that will help people who have suffered a stroke or aneurysm.  Volz reviews the newest addition to Medtronic’s pipeline as well as its innovative deal with Viz.ai, an artificial intelligence provider.

Daniel Volz, the newly named head of Medtronic’s neurovascular group, explains how the company is developing game-changing technologies into devices that will help people who have suffered a stroke or aneurysm. Volz reviews the newest addition to Medtronic’s pipeline as well as its innovative deal with Viz.ai, an artificial intelligence provider.

How Medtronic’s Neurovascular business is using AI and other new technology to save stroke patients

The MedtronicTalks Podcast Series brings insights, observation and lessons from the leaders of the medtech industry’s single, largest leader. Episodes will center around one of Medtronic’s business units ranging from cardiac care to surgical robotics. We’ll talk with decision-makers who keep Medtronic at the forefront of Medtech. We’ll also speak with regulatory, financial and other operational leaders including the CEO about how Medtronic is preparing for the future.

Share How Medtronic’s Neurovascular business is using AI and other new technology to save stroke patients

Sign up to save your podcasts

How Medtronic’s Neurovascular business is using AI and other new technology to save stroke patients

How Medtronic’s Neurovascular business is using AI and other new technology to save stroke patients